These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30704222)

  • 1. [A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees].
    Xu ZF; Qin TJ; Zhang HL; Fang LW; Hu NB; Pan LJ; Qu SQ; Li B; Yan X; Shi ZX; Huang HJ; Liu D; Cai YN; Zhang YD; Zhang PH; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):12-16. PubMed ID: 30704222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical features and prognostic analysis of 75 primary myelofibrosis patients].
    Yu Q; Xu L; Gao X; Xu W; Yan H; Wu W; Li J; Shen Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):922-5. PubMed ID: 25339331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of Clinical Features and Prognosis in 31 Patients with Primary Myelofibrosis].
    He HJ; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1721-8. PubMed ID: 26708900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of prognostic factors in Chinese patients with post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis].
    Chen M; Xu ZF; Xu JQ; Li B; Zhang PH; Qin TJ; Zhang Y; Wang JY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):876-880. PubMed ID: 27801320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of prognostic value of cytogenetics in patients with primary myelofibrosis].
    Li B; Xu J; Xu Z; Li C; Qin T; Fang L; Zhang H; Hu N; Pan L; Qu S; Wang J; Zhang Y; Zhang P; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):990-4. PubMed ID: 25417875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors of early septic shock-related thrombocytopenia and its impact on prognosis].
    Xu X; Wang H; Wu X; Yu J; Zheng R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):938-943. PubMed ID: 34590560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis.
    Lucijanic M; Veletic I; Rahelic D; Pejsa V; Cicic D; Skelin M; Livun A; Tupek KM; Stoos-Veic T; Lucijanic T; Maglicic A; Kusec R
    Wien Klin Wochenschr; 2018 Feb; 130(3-4):126-133. PubMed ID: 29372410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis.
    Wang J; Xu J; Gale RP; Xu Z; Li B; Qin T; Zhang Y; Fang L; Zhang H; Pan L; Qu S; Zhang P; Xiao Z
    Leuk Res; 2014 Oct; 38(10):1207-11. PubMed ID: 25182689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
    Masarova L; Bose P; Daver N; Pemmaraju N; Newberry KJ; Manshouri T; Cortes J; Kantarjian HM; Verstovsek S
    Leuk Res; 2017 Aug; 59():110-116. PubMed ID: 28601551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study.
    Zhang L; Ye X; Luo S; Xu X; Wang S; Jin K; Zheng Y; Zhu X; Chen D; Jin J; Huang J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2383-2392. PubMed ID: 35731275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms.
    Şahin E; Yönal-Hindilerden İ; Hindilerden F; Aday A; Nalçacı M
    Turk J Med Sci; 2022 Feb; 52(1):150-165. PubMed ID: 34482679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis.
    Lucijanic M; Livun A; Stoos-Veic T; Pejsa V; Jaksic O; Cicic D; Lucijanic J; Romic Z; Orehovec B; Aralica G; Miletic M; Kusec R
    Hematology; 2018 May; 23(4):201-207. PubMed ID: 28906207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
    Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
    J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
    Yan X; Qin TJ; Li B; Qu SQ; Pan LJ; Li FH; Liu NN; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):276-283. PubMed ID: 37356995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical Analysis of 66 Patients with Essential Thrombocytopenia].
    Zhang LJ; Shi YY; Chen Y; Gan YM; Shi WT; Chen KK; Ding BH; He ZM; Wang CL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1321-1325. PubMed ID: 32798420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.
    Lucijanic M; Mitrovic Z; Cicic D; Prka Z; Pejsa V; Livun A; Stoos-Veic T; Romic Z; Zivkovic M; Lucijanic I; Fabris Z; Kusec R
    Int J Hematol; 2018 Feb; 107(2):166-172. PubMed ID: 29022201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
    Iurlo A; Palandri F; Maria Elli E; Cattaneo D; Bucelli C; Sciumè M; Vincelli D; Brioschi F; Auteri G; Croci GA; Guerneri S; Isimbaldi G; Sabattini E; Cortinovis I; Bossi A; Rosti V; Martino B; Baldini L; Gianelli U
    Hematol Oncol; 2021 Feb; 39(1):123-128. PubMed ID: 32979286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.